A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML

Clinical Trial ID NCT02326584

PubWeight™ 4.69‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02326584

Top papers

Rank Title Journal Year PubWeight™‹?›
1 New drugs in acute myeloid leukemia. Ann Oncol 2016 0.88
2 Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches. Trends Pharmacol Sci 2015 0.84
3 Life after transplant: are we becoming high maintenance in AML? Bone Marrow Transplant 2016 0.75
4 Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials. Blood 2016 0.75
5 Acute myeloid leukemia: advancing clinical trials and promising therapeutics. Expert Rev Hematol 2016 0.75
6 New approaches for the immunotherapy of acute myeloid leukemia. Discov Med 2015 0.75
Next 100